• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性膀胱切除术前行C反应蛋白检测:术前C反应蛋白的测定

[C-reactive protein prior to radical cystectomy: preoperative determination of CRP].

作者信息

Kramer M W, Heinisch A, Wegener G, Abbas M, von Klot C, Peters I, Tezval H, Herrmann T R, Kuczyk M A, Merseburger A S

机构信息

Klinik für Urologie und Urologische Onkologie, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover, Deutschland.

出版信息

Urologe A. 2014 Feb;53(2):222-7. doi: 10.1007/s00120-013-3299-x.

DOI:10.1007/s00120-013-3299-x
PMID:23955283
Abstract

BACKGROUND

Numerous studies have shown a positive correlation between elevated C-reactive protein (CRP) and systemic spread of malignancies. The goal of the current study was to assess the predictive significance of preoperative CRP in patients undergoing radical cystectomy (RC).

MATERIAL AND METHODS

Preoperative CRP values were measured in 194 patients undergoing RC because of urothelial carcinoma between 1996 and 2005. Elevated CRP level was defined as ≥ 5 mg/l.

RESULTS

Preoperative increased CRP values were detected in 89 (45.9%) patients and these patients were more likely to have advanced tumor stages (pT3-4), positive resection margins and positive lymph nodes. Advanced urinary diversions were more common in patients with normal CRP values. In multivariate analysis, CRP was identified as an independent prognostic indicator for poor cancer-specific survival.

CONCLUSION

The results confirm previous reports that showed a prognostic significance of preoperative CRP elevation.

摘要

背景

大量研究表明,C反应蛋白(CRP)升高与恶性肿瘤的全身扩散之间存在正相关。本研究的目的是评估术前CRP在接受根治性膀胱切除术(RC)患者中的预测意义。

材料与方法

对1996年至2005年间因尿路上皮癌接受RC的194例患者进行术前CRP值测定。CRP水平升高定义为≥5mg/l。

结果

89例(45.9%)患者术前CRP值升高,这些患者更有可能出现肿瘤晚期(pT3-4)、切缘阳性和淋巴结阳性。CRP值正常的患者更常采用高级尿流改道术。多因素分析显示,CRP是癌症特异性生存率低的独立预后指标。

结论

结果证实了先前的报道,即术前CRP升高具有预后意义。

相似文献

1
[C-reactive protein prior to radical cystectomy: preoperative determination of CRP].根治性膀胱切除术前行C反应蛋白检测:术前C反应蛋白的测定
Urologe A. 2014 Feb;53(2):222-7. doi: 10.1007/s00120-013-3299-x.
2
Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.基于术前血清 C 反应蛋白和标准病理危险因素的膀胱癌新预后预测模型的建立:TNR-C 评分。
BJU Int. 2011 Dec;108(11):1800-5. doi: 10.1111/j.1464-410X.2011.10234.x. Epub 2011 Apr 20.
3
Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up.根治性膀胱切除术治疗尿路上皮膀胱癌患者常规实验室参数的影响:长期随访。
Urol Int. 2020;104(7-8):551-558. doi: 10.1159/000506263. Epub 2020 Feb 28.
4
Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study.术前血红蛋白和CRP水平对膀胱移行细胞癌根治性膀胱切除术患者癌症特异性生存的影响:一项单中心研究结果
World J Urol. 2016 May;34(5):703-8. doi: 10.1007/s00345-015-1680-7. Epub 2015 Sep 16.
5
Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?术前中性粒细胞与淋巴细胞比值能否显著预测接受根治性膀胱切除术的肌层浸润性膀胱癌患者的条件生存概率?
Clin Genitourin Cancer. 2017 Jun;15(3):e411-e420. doi: 10.1016/j.clgc.2016.10.015. Epub 2017 Jan 9.
6
A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.根治性膀胱切除术治疗后癌症特异性生存的新预后模型,包括预处理血小板增多症和标准病理危险因素。
BJU Int. 2012 Dec;110(11 Pt B):E533-40. doi: 10.1111/j.1464-410X.2012.11231.x. Epub 2012 May 11.
7
Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.根治性膀胱切除术治疗的膀胱癌患者,术前中性粒细胞与淋巴细胞比值与晚期病理肿瘤分期和癌症特异性死亡率增加相关。
Eur Urol. 2014 Dec;66(6):1157-64. doi: 10.1016/j.eururo.2014.02.042. Epub 2014 Feb 26.
8
Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.术前慢性肾脏病可预测膀胱癌根治性切除术的肿瘤学结局。
World J Urol. 2018 Feb;36(2):249-256. doi: 10.1007/s00345-017-2141-2. Epub 2017 Nov 28.
9
Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological Outcome.膀胱癌行根治性膀胱切除术患者的术前血小板增多症:影响肿瘤学预后的独立预后参数。
Urol Int. 2020;104(1-2):36-41. doi: 10.1159/000500729. Epub 2019 Jun 26.
10
Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis.根治性膀胱切除术治疗膀胱癌患者术前血液生物标志物的预后价值:系统评价和荟萃分析。
Int J Clin Oncol. 2020 Aug;25(8):1459-1474. doi: 10.1007/s10147-020-01690-1. Epub 2020 May 26.

引用本文的文献

1
C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy.C反应蛋白与白蛋白比值作为接受放化疗的局部晚期非小细胞肺癌的预后标志物
Biomedicines. 2022 Mar 3;10(3):598. doi: 10.3390/biomedicines10030598.
2
Role of Systemic Inflammatory Response Markers in Urothelial Carcinoma.全身炎症反应标志物在尿路上皮癌中的作用
Front Oncol. 2020 Aug 21;10:1473. doi: 10.3389/fonc.2020.01473. eCollection 2020.
3
Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study.

本文引用的文献

1
Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling.根治性膀胱切除术后辅助化疗咨询的 pT1-3N0 患者的风险分层。
Br J Cancer. 2012 Nov 20;107(11):1826-32. doi: 10.1038/bjc.2012.464.
2
Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients.验证 CRP 作为大系列患者肾细胞癌的预后标志物。
BMC Cancer. 2012 Sep 8;12:399. doi: 10.1186/1471-2407-12-399.
3
Development of a nomogram to predict non-organ-confined bladder urothelial cancer before radical cystectomy.
术前C反应蛋白/白蛋白比值是根治性膀胱切除术后膀胱癌患者生存的重要预测指标:一项回顾性研究
Cancer Manag Res. 2018 Oct 23;10:4789-4804. doi: 10.2147/CMAR.S180301. eCollection 2018.
4
Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis.C反应蛋白在泌尿系统癌症中的预后作用:一项荟萃分析
Sci Rep. 2015 Aug 3;5:12733. doi: 10.1038/srep12733.
建立预测根治性膀胱切除术前非器官局限型膀胱尿路上皮癌的列线图。
Int Urol Nephrol. 2012 Dec;44(6):1711-9. doi: 10.1007/s11255-012-0273-2. Epub 2012 Sep 1.
4
Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma.术前循环骨桥蛋白、碳酸酐酶 IX 和 CRP 在肾细胞癌中的预后价值。
Br J Cancer. 2012 Sep 25;107(7):1131-7. doi: 10.1038/bjc.2012.360. Epub 2012 Aug 23.
5
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.全球癌症发病趋势与人类发展指数(2008-2030 年):基于人群的研究。
Lancet Oncol. 2012 Aug;13(8):790-801. doi: 10.1016/S1470-2045(12)70211-5. Epub 2012 Jun 1.
6
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
7
Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.基于术前血清 C 反应蛋白和标准病理危险因素的膀胱癌新预后预测模型的建立:TNR-C 评分。
BJU Int. 2011 Dec;108(11):1800-5. doi: 10.1111/j.1464-410X.2011.10234.x. Epub 2011 Apr 20.
8
The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study.癌症的存在与部位、基于炎症的预后评分与生化参数之间的关系。格拉斯哥炎症结局研究的初步结果。
Br J Cancer. 2010 Sep 7;103(6):870-6. doi: 10.1038/sj.bjc.6605855. Epub 2010 Aug 17.
9
Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens.铂类药物治疗失败的晚期尿路上皮移行细胞癌患者的预后因素。
J Clin Oncol. 2010 Apr 10;28(11):1850-5. doi: 10.1200/JCO.2009.25.4599. Epub 2010 Mar 15.
10
C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results.C-反应蛋白作为去势抵抗性前列腺癌(CRPC)男性的不良预后标志物:确证结果。
Urol Oncol. 2012 Jan-Feb;30(1):33-7. doi: 10.1016/j.urolonc.2009.11.012. Epub 2010 Mar 6.